Daping Xu has extensive experience in the pharmaceutical industry, having served in several leadership roles, including Director at Skyline Therapeutics from 2022 to 2025 and currently at 先声药业 since 2025. Previously, Daping was an Associate Director at 恒瑞医药 from 2021 to 2022 and held various positions at Jiangsu Hengrui Medicine Co., Ltd., including Preclinical Project Manager from 2017 to 2019 and Assistant Director (Preclinical) from 2020 to 2021. Daping holds a Doctor of Philosophy in Pharmacology from The Hong Kong Polytechnic University and a Master of Science in Pharmacology from 澳门大学, following a Bachelor’s degree in Clinical and Industrial Drug Development from 中国医科大学.
This person is not in the org chart
This person is not in any teams
This person is not in any offices